Magnesium sulfate (medical use) solution. In the United Kingdom 4 ml of 20% solution costs the NHS about 10.23 pounds. In the United States a course of medication typically costs less than $25. Magnesium sulfate is the primary treatment and preventative measure in women with eclampsia. It lowers systolic blood pressure while maintaining diastolic blood pressure, thus leaving blood flow to the fetus uncompromised. Magnesium sulphate was once used as a tocolytic, but meta-analyses have failed to support it as an anti-contraction medication. Usage for prolonged periods (more than five to seven days) may result in health problems for the baby. In those at
Low valent magnesium compounds Low valent magnesium compounds A number of stable low valent magnesium compounds containing a metal-metal, Mg-Mg, bond, where magnesium exhibits the formal oxidation state of +1 are known. These compounds generally have the formula LMg, where L represents a bulky ligand. The first examples of these stable magnesium(I) compounds were reported in 2007. The chemistry of Mg is dominated by the +2 oxidation state and prior to 2007 only examples of crystalline compounds with short Mg-Mg distances that may indicate an Mg-Mg bond were known, such as the ternary metal hydrides MgRuH, MgRuH, and MgIrH and magnesium diboride, Calculations had